About establishment labs holdings inc - ESTA
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.
ESTA At a Glance
Establishment Labs Holdings, Inc.
Building B15 and 25
Coyol, Alajuela
| Phone | 506-2434-2400 | Revenue | 166.03M | |
| Industry | Medical Specialties | Net Income | -84,596,000.00 | |
| Sector | Health Technology | 2024 Sales Growth | 0.529% | |
| Fiscal Year-end | 12 / 2025 | Employees | 1,018 | |
| View SEC Filings |
ESTA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 7.815 |
| Price to Book Ratio | 24.978 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -33.774 |
| Enterprise Value to Sales | 8.627 |
| Total Debt to Enterprise Value | 0.157 |
ESTA Efficiency
| Revenue/Employee | 163,089.391 |
| Income Per Employee | -83,100.196 |
| Receivables Turnover | 2.554 |
| Total Asset Turnover | 0.54 |
ESTA Liquidity
| Current Ratio | 3.56 |
| Quick Ratio | 2.391 |
| Cash Ratio | 1.323 |
ESTA Profitability
| Gross Margin | 65.969 |
| Operating Margin | -30.108 |
| Pretax Margin | -50.973 |
| Net Margin | -50.954 |
| Return on Assets | -27.49 |
| Return on Equity | -236.665 |
| Return on Total Capital | -30.388 |
| Return on Invested Capital | -34.762 |
ESTA Capital Structure
| Total Debt to Total Equity | 424.322 |
| Total Debt to Total Capital | 80.928 |
| Total Debt to Total Assets | 64.958 |
| Long-Term Debt to Equity | 421.471 |
| Long-Term Debt to Total Capital | 80.384 |